Literature DB >> 27667756

Segmental-dependent permeability throughout the small intestine following oral drug administration: Single-pass vs. Doluisio approach to in-situ rat perfusion.

Isabel Lozoya-Agullo1, Moran Zur2, Avital Beig2, Noa Fine2, Yael Cohen2, Marta González-Álvarez3, Matilde Merino-Sanjuán4, Isabel González-Álvarez3, Marival Bermejo3, Arik Dahan5.   

Abstract

Intestinal drug permeability is position dependent and pertains to a specific point along the intestinal membrane, and the resulted segmental-dependent permeability phenomenon has been recognized as a critical factor in the overall absorption of drug following oral administration. The aim of this research was to compare segmental-dependent permeability data obtained from two different rat intestinal perfusion approaches: the single-pass intestinal perfusion (SPIP) model and the closed-loop (Doluisio) rat perfusion method. The rat intestinal permeability of 12 model drugs with different permeability characteristics (low, moderate, and high, as well as passively and actively absorbed) was assessed in three small intestinal regions: the upper jejunum, mid-small intestine, and the terminal ileum, using both the SPIP and the Doluisio experimental methods. Excellent correlation was evident between the two approaches, especially in the upper jejunum (R2=0.95). Significant regional-dependent permeability was found in half of drugs studied, illustrating the importance and relevance of segmental-dependent intestinal permeability. Despite the differences between the two methods, highly comparable results were obtained by both methods, especially in the medium-high Peff range. In conclusion, the SPIP and the Doluisio method are both equally useful in obtaining crucial segmental-dependent intestinal permeability data. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biopharmaceutics classification system; Intestinal permeability; Oral drug absorption; Segmental-dependent permeability

Mesh:

Substances:

Year:  2016        PMID: 27667756     DOI: 10.1016/j.ijpharm.2016.09.061

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

1.  Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat-Biophysical Model and Predictions Based on Caco-2.

Authors:  Isabel Lozoya-Agullo; Isabel Gonzalez-Alvarez; Moran Zur; Noa Fine-Shamir; Yael Cohen; Milica Markovic; Teresa M Garrigues; Arik Dahan; Marta Gonzalez-Alvarez; Matilde Merino-Sanjuán; Marival Bermejo; Alex Avdeef
Journal:  Pharm Res       Date:  2017-12-29       Impact factor: 4.200

2.  Advantageous Solubility-Permeability Interplay When Using Amorphous Solid Dispersion (ASD) Formulation for the BCS Class IV P-gp Substrate Rifaximin: Simultaneous Increase of Both the Solubility and the Permeability.

Authors:  Avital Beig; Noa Fine-Shamir; David Lindley; Jonathan M Miller; Arik Dahan
Journal:  AAPS J       Date:  2017-02-15       Impact factor: 4.009

3.  Measuring the Impact of Gastrointestinal Variables on the Systemic Outcome of Two Suspensions of Posaconazole by a PBPK Model.

Authors:  Bart Hens; Arjang Talattof; Paulo Paixão; Marival Bermejo; Yasuhiro Tsume; Raimar Löbenberg; Gordon L Amidon
Journal:  AAPS J       Date:  2018-03-29       Impact factor: 4.009

4.  Quercetin-Conjugated Superparamagnetic Iron Oxide Nanoparticles Protect AlCl3-Induced Neurotoxicity in a Rat Model of Alzheimer's Disease via Antioxidant Genes, APP Gene, and miRNA-101.

Authors:  Elnaz Amanzadeh Jajin; Abolghasem Esmaeili; Soheila Rahgozar; Maryam Noorbakhshnia
Journal:  Front Neurosci       Date:  2021-02-25       Impact factor: 4.677

5.  The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of Minoxidil.

Authors:  Milica Markovic; Moran Zur; Sapir Garsiani; Daniel Porat; Sandra Cvijić; Gordon L Amidon; Arik Dahan
Journal:  Pharmaceutics       Date:  2022-06-27       Impact factor: 6.525

6.  A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP.

Authors:  Marival Bermejo; Bart Hens; Joseph Dickens; Deanna Mudie; Paulo Paixão; Yasuhiro Tsume; Kerby Shedden; Gordon L Amidon
Journal:  Pharmaceutics       Date:  2020-01-17       Impact factor: 6.321

7.  Synthesis and Evaluation of PEG-PR for Water Flux Correction in an In Situ Rat Perfusion Model.

Authors:  Guo Chen; Xingqi Min; Qunqun Zhang; Zhiqiang Zhang; Meiqiang Wen; Jun Yang; Meijuan Zou; Wei Sun; Gang Cheng
Journal:  Molecules       Date:  2020-11-04       Impact factor: 4.411

8.  Integration of In Silico, In Vitro and In Situ Tools for the Preformulation and Characterization of a Novel Cardio-Neuroprotective Compound during the Early Stages of Drug Development.

Authors:  Claudia Miranda; Alejandro Ruiz-Picazo; Paula Pomares; Isabel Gonzalez-Alvarez; Marival Bermejo; Marta Gonzalez-Alvarez; Alex Avdeef; Miguel-Ángel Cabrera-Pérez
Journal:  Pharmaceutics       Date:  2022-01-13       Impact factor: 6.321

9.  Square root law model for the delivery and intestinal absorption of drugs: a case of hydrophilic captopril.

Authors:  Valentina Anuta; Constantin Mircioiu; Victor Voicu; Ion Mircioiu; Roxana Sandulovici
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.